The 41st Annual General Meeting Meeting of the Members of the Company was held on Friday July, 31, 2026 at 12:00 Noon through VC/OAVM. The summary of the proceedings are published herewith.

Concord Biotech Ltd held its 41st Annual General Meeting on July 31, 2026, through video conferencing. The meeting was attended by 38 members, and the requisite quorum was present. The Chairman and Managing Director, Mr. Sudhir Vaid, addressed the shareholders and gave an overview of the company's operations and financial performance for the year ended March 31, 2026. The meeting was conducted in accordance with the provisions of the Companies Act, 2013, and the Statutory Auditors' Report and the Secretarial Audit Report did not contain any qualification, reservation, adverse remark, or disclaimer.